Influencing factors for intraoperative choking during painless gastrointestinal endoscopy in patients recovered from coronavirus disease 2019_West China Medical Journal

Authors：

JI Wenxuan ¹ , LIU Xin ² ,  GAO Ju ²

1. Department of Anesthesiology, the Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu 225001, P. R. China;
2. Department of Anesthesiology, Northern Jiangsu People’s Hospital, Yangzhou, Jiangsu 225001, P. R. China;

Corresponding?author：

GAO Ju, Email: doctor2227@163.com

Keywords：

COVID-19; painless gastrointestinal endoscopy; intraoperative choking; risk factors; protective factors

DOI：

10.7507/1002-0179.202403079

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To determine the independent influencing factors of intraoperative choking during painless gastrointestinal endoscopy (PGIE) after coronavirus disease 2019 (COVID-19). Methods The data of patients undergoing PGIE with COVID-19 in Northern Jiangsu People’s Hospital between December 2022 and April 2023 were retrospectively collected. Multiple logistic regression analysis was used to screen the influencing factors of intraoperative coughing events that occurred during the diagnosis and treatment process. Results A total of 948 patients were included, with 93 (9.8%) cases of choking. The results of the multiple logistic regression analysis showed that smoking and unresolved cough were independent risk factors for coughing (P<0.05), while colonoscopy and infection duration beyond 14 days between diagnosis and treatment were independent protective factors for coughing (P<0.05). Conclusions When patients with COVID-19 undergoing PGIE, special attention should be paid to high-risk groups such as smoking and unresolved cough. It is necessary to strengthen intraoperative monitoring and implementation of prevention and control measures to reduce the incidence of coughing and improve the safety of diagnosis and treatment for patients.

Citation： JI Wenxuan, LIU Xin, GAO Ju. Influencing factors for intraoperative choking during painless gastrointestinal endoscopy in patients recovered from coronavirus disease 2019. West China Medical Journal, 2024, 39(11): 1738-1743. doi: 10.7507/1002-0179.202403079 Copy

1.	Ren W, Zhu Y, Lan J, et al. Susceptibilities of human ACE2 genetic variants in coronavirus infection. J Virol, 2022, 96(1): e0149221.
2.	郭藝飛, 張繼明. 嚴重急性呼吸綜合征冠狀病毒 2 Omicron 變異株研究進展. 微生物與感染, 2022, 17(1): 2-8.
3.	Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nat, 2022, 604(7907): 697-707.
4.	中華人民共和國國家衛生健康委員會. 新型冠狀病毒感染診療方案(試行第十版). 中國合理用藥探索, 2023, 20(1): 1-11.
5.	Mason KP, Green SM, Piacevoli Q. Adverse event reporting tool to standardize the reporting and tracking of adverse events during procedural sedation: a consensus document from the world siva international sedation task force. Br J Anaesth, 2012, 108(1): 13-20.
6.	李濤, 張允嶺, 趙暉, 等. 吸煙與腦卒中高危人群頸動脈粥樣硬化發生的相關性分析. 中西醫結合心腦血管病雜志, 2015, 13(2): 175-178.
7.	梁彪, 胡琳琍, 王芳, 等. 無痛胃鏡診療的臨床應用. 中國內鏡雜志, 2006, 12(5): 520-523.
8.	中華醫學會麻醉學分會氣道管理學組. 新型冠狀病毒肺炎危重型患者氣管插管術的專家建議 (1.0 版). 中華麻醉學雜志, 2020, 40(3): 287-290.
9.	王梓, 劉昕, 高巨. 老年患者無痛胃腸鏡檢查術后 PACU 滯留時間延長的危險因素. 中華麻醉學雜志, 2023, 43(2): 146-151.
10.	劉婉君, 陳麗萍. 吸煙對下呼吸道誘導痰中 IFN-γ、IL-4、IL-5 表達的影響. 中國微生態學雜志, 2018, 30(7): 795-797, 801.
11.	祁聞, 李仁奇, 袁亮, 等. 吸煙對無痛胃鏡檢查男性患者丙泊酚用量的影響. 臨床麻醉學雜志, 2018, 34(11): 1092-1094.
12.	楊偉東, 李雙月, 江仁, 等. 全身麻醉術后下呼吸道感染相關影響因素分析. 中華醫院感染學雜志, 2018, 28(9): 1374-1376.
13.	中華醫學會呼吸病學分會哮喘學組. 咳嗽的診斷與治療指南(2015). 中華結核和呼吸雜志, 2016, 39(5): 323-354.
14.	龍茹華, 秦婷婷, 邵建林. 布地奈德霧化吸入預防感染后咳嗽患者無痛胃鏡檢查嗆咳發生. 昆明醫科大學學報, 2018, 39(2): 76-79.
15.	謝金鳳. 孟魯斯特聯合霧化吸入治療小兒感染后咳嗽的療效觀察. 世界最新醫學信息文摘, 2021, 21(95): 204-205.
16.	Moscarino S, K?tter F, Brandt M, et al. Influence of different surgical concepts for moderate skeletal class Ⅱ and Ⅲ treatment on the nasopharyngeal airway space. J Craniomaxillofac Surg, 2019, 47(10): 1489-1497.
17.	Kawasuji H, Morinaga Y, Tani H, et al. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. J Med Virol, 2022, 94(1): 147-153.

1. Ren W, Zhu Y, Lan J, et al. Susceptibilities of human ACE2 genetic variants in coronavirus infection. J Virol, 2022, 96(1): e0149221.
2. 郭藝飛, 張繼明. 嚴重急性呼吸綜合征冠狀病毒 2 Omicron 變異株研究進展. 微生物與感染, 2022, 17(1): 2-8.
3. Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nat, 2022, 604(7907): 697-707.
4. 中華人民共和國國家衛生健康委員會. 新型冠狀病毒感染診療方案(試行第十版). 中國合理用藥探索, 2023, 20(1): 1-11.
5. Mason KP, Green SM, Piacevoli Q. Adverse event reporting tool to standardize the reporting and tracking of adverse events during procedural sedation: a consensus document from the world siva international sedation task force. Br J Anaesth, 2012, 108(1): 13-20.
6. 李濤, 張允嶺, 趙暉, 等. 吸煙與腦卒中高危人群頸動脈粥樣硬化發生的相關性分析. 中西醫結合心腦血管病雜志, 2015, 13(2): 175-178.
7. 梁彪, 胡琳琍, 王芳, 等. 無痛胃鏡診療的臨床應用. 中國內鏡雜志, 2006, 12(5): 520-523.
8. 中華醫學會麻醉學分會氣道管理學組. 新型冠狀病毒肺炎危重型患者氣管插管術的專家建議 (1.0 版). 中華麻醉學雜志, 2020, 40(3): 287-290.
9. 王梓, 劉昕, 高巨. 老年患者無痛胃腸鏡檢查術后 PACU 滯留時間延長的危險因素. 中華麻醉學雜志, 2023, 43(2): 146-151.
10. 劉婉君, 陳麗萍. 吸煙對下呼吸道誘導痰中 IFN-γ、IL-4、IL-5 表達的影響. 中國微生態學雜志, 2018, 30(7): 795-797, 801.
11. 祁聞, 李仁奇, 袁亮, 等. 吸煙對無痛胃鏡檢查男性患者丙泊酚用量的影響. 臨床麻醉學雜志, 2018, 34(11): 1092-1094.
12. 楊偉東, 李雙月, 江仁, 等. 全身麻醉術后下呼吸道感染相關影響因素分析. 中華醫院感染學雜志, 2018, 28(9): 1374-1376.
13. 中華醫學會呼吸病學分會哮喘學組. 咳嗽的診斷與治療指南(2015). 中華結核和呼吸雜志, 2016, 39(5): 323-354.
14. 龍茹華, 秦婷婷, 邵建林. 布地奈德霧化吸入預防感染后咳嗽患者無痛胃鏡檢查嗆咳發生. 昆明醫科大學學報, 2018, 39(2): 76-79.
15. 謝金鳳. 孟魯斯特聯合霧化吸入治療小兒感染后咳嗽的療效觀察. 世界最新醫學信息文摘, 2021, 21(95): 204-205.
16. Moscarino S, K?tter F, Brandt M, et al. Influence of different surgical concepts for moderate skeletal class Ⅱ and Ⅲ treatment on the nasopharyngeal airway space. J Craniomaxillofac Surg, 2019, 47(10): 1489-1497.
17. Kawasuji H, Morinaga Y, Tani H, et al. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. J Med Virol, 2022, 94(1): 147-153.

West China Medical Journal

Influencing factors for intraoperative choking during painless gastrointestinal endoscopy in patients recovered from coronavirus disease 2019

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content